Vertex Pharmaceuticals (WBO:VRTX) Change In Prepaid Assets : €-309 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Vertex Pharmaceuticals Change In Prepaid Assets?

Vertex Pharmaceuticals's Change In Prepaid Assets for the quarter that ended in Mar. 2025 was €-26 Mil. It means Vertex Pharmaceuticals's Prepaid Assets declined by €26 Mil from Dec. 2024 to Mar. 2025 .

Vertex Pharmaceuticals's Change In Prepaid Assets for the fiscal year that ended in Dec. 2024 was €-191 Mil. It means Vertex Pharmaceuticals's Prepaid Assets declined by €191 Mil from Dec. 2023 to Dec. 2024 .

Vertex Pharmaceuticals Change In Prepaid Assets Historical Data

The historical data trend for Vertex Pharmaceuticals's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vertex Pharmaceuticals Change In Prepaid Assets Chart

Vertex Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Prepaid Assets

Get a 7-Day Free Trial

-244.63

-81.24

-308.12

-500.41

-191.29

Vertex Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Prepaid Assets	Get a 7-Day Free Trial															91.26	-144.83	18.92	-157.19	-25.99

Vertex Pharmaceuticals Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-309 Mil.

Vertex Pharmaceuticals Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Vertex Pharmaceuticals's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Vertex Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vertex Pharmaceuticals Inc (WBO:VRTX) » Definitions » Change In Prepaid Assets

Comparable Companies

Traded in Other Exchanges

VRTX:USA VRTX:Mexico 1VRTX:Italy 0QZU:UK VX1:Germany VX1:Germany VX1:Germany VRTX34:Brazil

Address

50 Northern Avenue, Boston, MA, USA, 02210

Website

https://www.vrtx.com

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.